OmniAb Reports After Three Guidance Raises and a Stock That Doubled Between Quarters
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
OmniAb reports earnings before market open, meaning Day 0 represents the first full trading session where investors react to results, while Day +1 captures follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-08-06 | +$0.21 (+10.34%) | $0.23 (11.33%) | +$0.84 (+37.50%) | $0.77 (34.29%) |
| 2026-05-07 | +$0.04 (+2.80%) | $0.06 (4.20%) | +$0.19 (+12.93%) | $0.17 (11.56%) |
| 2026-03-04 | +$0.08 (+4.62%) | $0.10 (6.07%) | +$0.19 (+10.50%) | $0.30 (16.57%) |
| 2025-11-04 | +$0.00 (+0.00%) | $0.07 (4.73%) | -$0.05 (-3.72%) | $0.19 (12.73%) |
| 2025-08-06 | -$0.11 (-5.39%) | $0.18 (8.83%) | -$0.05 (-2.59%) | $0.29 (15.28%) |
| 2025-05-08 | +$0.04 (+2.61%) | $0.09 (5.88%) | -$0.13 (-8.28%) | $0.19 (12.10%) |
| 2025-03-18 | +$0.02 (+0.63%) | $0.10 (3.10%) | -$0.65 (-20.38%) | $0.60 (18.81%) |
| 2024-11-12 | -$0.11 (-2.39%) | $0.18 (3.91%) | -$0.42 (-9.35%) | $0.34 (7.57%) |
| Avg Abs Move | 3.60% | 6.01% | 13.15% | 16.12% |
Historical price behavior shows significant volatility around OmniAb earnings releases, with an average absolute Day 0 move of 3.60% and Day +1 move of 13.15%. The most dramatic reaction came after the August 2026 report, when the stock surged 10.34% on Day 0 and extended gains to 37.50% by Day +1 following the substantial earnings beat. Conversely, the March 2025 report triggered a 20.38% decline on Day +1 despite a modest positive Day 0 reaction.
The pattern reveals that initial market reactions often understate the ultimate price impact—the average Day +1 range of 16.12% is nearly triple the Day 0 range of 6.01%. This suggests investors take time to digest the implications of OmniAb's results, particularly given the company's lumpy revenue model and complex partnership economics. Recent reports have skewed positive, with the last two earnings releases producing substantial multi-day gains, but the historical average shows considerable two-way risk.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 11/20/26 (DTE 22) |
| Expected Move | $0.48 (9.26%) |
| Expected Range | $4.75 to $5.71 |
| Implied Volatility | 102.84% |
The options market is pricing a 9.26% expected move for this earnings release, which sits below the stock's average historical Day +1 move of 13.15% but above the average Day 0 move of 3.60%. This suggests options traders are anticipating a meaningful but not extreme reaction—potentially underpricing the volatility risk given OmniAb's recent pattern of outsized post-earnings moves exceeding 30%.
Part 3: What Analysts Are Saying
Analyst sentiment on OmniAb is overwhelmingly bullish, with the consensus firmly in buy territory. The current breakdown shows 7 Strong Buy ratings and 1 Hold, with zero sell recommendations. The average price target of $8.33 implies 59% upside from the current price of $5.23, with individual targets ranging from a low of $5.00 to a high of $12.00.
Sentiment has remained unchanged over the past month, indicating stable conviction among the analyst community despite the stock's recent rally. The consistency of bullish ratings suggests analysts believe OmniAb's technology platform and partnership model have significant untapped value that hasn't been fully reflected in the share price.
The wide range between the high and low price targets ($5.00 to $12.00) reflects differing views on execution risk and the timeline to profitability. Bulls see the company's AI-powered discovery platform and expanding partner network as drivers of accelerating revenue growth and eventual margin expansion. The lone Hold rating likely reflects valuation concerns after the stock's 94% year-to-date gain, though even this cautious view doesn't extend to a sell recommendation. With full-year 2027 losses expected to improve 37% to $-0.22 per share, the Street appears confident in management's ability to scale the business toward breakeven.
Part 4: Technical Picture
OmniAb enters earnings with strong technical momentum across all timeframes. The Barchart Technical Opinion currently shows a 100% Buy signal, unchanged from both one week and one month ago, indicating sustained bullish conviction heading into the report.
Timeframe Analysis:
- Short-term (100% Buy): Maximum buy signal reflects powerful near-term momentum as the stock trades at multi-year highs
- Medium-term (100% Buy): Continued strength in the intermediate timeframe confirms the uptrend is well-established beyond just short-term speculation
- Long-term (100% Buy): Unanimous bullish reading across the longer-term horizon suggests a fundamental shift in the stock's trajectory
Trend Characteristics: The technical setup shows Maximum strength with a Strengthening direction, indicating the stock is in a powerful uptrend with accelerating momentum heading into earnings.
The stock is trading above all key moving averages, including the 5-day ($4.95), 10-day ($4.87), 20-day ($4.78), 50-day ($4.64), 100-day ($3.54), and 200-day ($2.69). This complete alignment with the current price at $5.23 above every major moving average is a textbook bullish configuration, showing strong support at multiple levels.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $4.95 | 50-Day MA | $4.64 |
| 10-Day MA | $4.87 | 100-Day MA | $3.54 |
| 20-Day MA | $4.78 | 200-Day MA | $2.69 |
The stock's position near its 52-week high of $5.43 and well above all moving averages creates a technically supportive but elevated setup for earnings. While the uptrend remains intact with no overhead resistance until the recent high, the extended nature of the rally means any disappointment could trigger profit-taking back toward the 20-day moving average at $4.78. Conversely, another earnings beat could propel the stock through $5.43 toward the analyst consensus target zone. The technical picture is constructive but leaves little room for error given the stock's 94% year-to-date advance.